TargetMol

Niflumic acid

Product Code:
 
TAR-T0693
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T0693-50mg50mg£106.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T0693-1mL1 mL * 10 mM (in DMSO)£111.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T0693-100mg100mg£114.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T0693-200mg200mg£131.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T0693-500mg500mg£166.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Niflumic acid is a Ca2+-activated Cl- channel blocker and an analgesic and anti-inflammatory agent used in the therapy of rheumatoid arthritis.
CAS:
4394-00-7
Formula:
C13H9F3N2O2
Molecular Weight:
282.222
Pathway:
Immunology/Inflammation; Metabolism; ; Neuroscience; Membrane transporter/Ion channel
Purity:
0.9979
SMILES:
OC(=O)c1cccnc1Nc1cccc(c1)C(F)(F)F
Target:
Phospholipase; Chloride channel; COX; Monocarboxylate transporter; UGT

References

1. White MM, et al. Mol Pharmacol, 1990, 37(5), 720-724. 2. Goelein H, et al. FEBS Lett, 1990, 268(1), 79-82. 3. Ottolia M, et al. Biophys J, 1994, 67(6), 2272-2279. 4. Hogg RC, et al. Br J Pharmacol, 1994, 112(3), 977-984. 5. Kuang Y, Chai Y, Xu L, et al. Glabrone as a specific UGT1A9 probe substrate and its application in discovering the inhibitor glycycoumarin[J]. European Journal of Pharmaceutical Sciences. 2021: 105786.